Navigation Links
MicroCHIPS Honored With 2010 Edison Best New Product Award
Date:4/30/2010

BEDFORD, Mass., April 30 /PRNewswire/ -- MicroCHIPS, Inc., a developer of intelligent implant systems, today announced that it has received a 2010 Edison Best New Product Award™ for its Illume™ product. The product was awarded Gold in the Science and Medical Category, recognizing the benefit that it will bring to millions of people with diabetes who must manage their blood sugar intensively to stay healthy.

"We are very honored to receive this award, as it demonstrates our innovative approach and the value that our product can bring to people who struggle daily with the demands of insulin-requiring diabetes," said Ajit Gill, president and CEO of MicroCHIPS. "By applying our unique microreservoir technology to create long-lived, in-body glucose sensors, we believe we can help people manage their diabetes with much more ease and with better results."  

The Illume™ Continuous Glucose Management System is being created as part of the next generation of consumer-focused diabetes management tools.  The system is a long-term, multi-sensor implant designed to wirelessly deliver continuous, convenient, reliable and accurate glucose measurements for a full year.  Designed to be placed just under the skin, this breakthrough product is currently undergoing testing with the goal of reaching the market in the next few years.

"Innovation is more important now than ever," said Sarah Miller Caldicott, great grand-niece of Thomas Edison and Chair of the Edison Best New Product Awards. "The Edison Award winners are the moving parts in the engine of economic growth. They inspire people to think outside the box and improve the lives of people around the world."

About the Edison Awards

The Edison Awards, a peer-review honor similar to the Oscars, is voted on by roughly 2,000 members of the not-for-profit Marketing Executives Networking Group (MENG), America's top executives and academics. The awards symbolize the persistence and excellence personified by Thomas Alva Edison, inspiring America's drive to remain in the forefront of innovation, creativity and ingenuity in the global economy.  

About MicroCHIPS

MicroCHIPS, Inc. is pioneering intelligent implanted devices designed to improve the health of millions of people with critical conditions that require careful monitoring and precise therapy. First developed at the Massachusetts Institute of Technology, MicroCHIPS' technologies use microreservoir arrays to store and protect chemical sensors or potent drugs within the body for extended periods of time. The reservoir arrays are compatible with preprogrammed microprocessors, wireless communications and sensor feedback loops to provide precise, dynamic control of drug release and in-body biochemical monitoring. For more information, please visit our Web site at www.mchips.com.


'/>"/>
SOURCE MicroCHIPS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MicroCHIPS CEO Named in Popular Sciences Seventh Annual Brilliant 10
2. A new material could act as a nanofridge for microchips
3. MIT reports finer lines for microchips
4. Melting defects could lead to smaller, more powerful microchips
5. Dr. Chang-Hwan Choi honored with prestigious Young Investigator Award
6. LaVoie Group Honored by LACP with Two Awards
7. CenterWatch Honored a Fifth Consecutive Year for Best Healthcare Content
8. Researcher honored for experimental work in nanotechnology
9. Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research
10. Booshoot Founder & CEO Jackie Heinricher Honored as Visionary Entrepreneur by Martha Stewart
11. Sigma-Aldrich Honored With CIO 100 Award for Innovative Web Research Tool, Your Favorite Gene powered by Ingenuity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  GlobeImmune, Inc. today announced it has entered ... 12,835,490 shares of its common stock to NantCell, Inc., ... with the sale of its common stock, NantCell has ... to GlobeImmune 200,000 shares, an estimated $2.0 million in ... are pleased to enter into this strategic agreement with ...
(Date:3/23/2017)... , March 23, 2017 NetworkNewsWire ... ... death, putting significant strain on health care systems, in terms ... diagnoses rises, so too does the development of innovative and ... side effects. Among the many types of cancer treatments, a ...
(Date:3/23/2017)... La. (PRWEB) , ... March 23, 2017 , ... ... industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as ... customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has ...
(Date:3/22/2017)... MONICA, Calif. , March 22, 2017 /PRNewswire/ ... are proud to announce their extended partnership and ... will be headlined by the 21 st ... BIOMEDevice Boston, taking place May 3-4, 2017. ... Advanced Medical Technology Association (ADVAMED) President and CEO, ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
(Date:2/28/2017)... LOS ANGELES , Feb. 28, 2017   ... identity verification software globally, announces significant enhancements to new ... in May 2016. New products include mobile and desktop ... and DocX TM - a real time manual ... Acuant,s core idScan® technology provides the fastest and most ...
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ein ... wird seine erstklassige biometrische Lösung zur Iris-Erkennung ... mit X16 LTE auf dem Mobile World ... am Qualcomm-Stand in Halle 3, Stand 3E10, ... die Sicherheitsplattform Qualcomm Haven™ – eine Kombination ...
Breaking Biology News(10 mins):